AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20851549
Drug: 30-min infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 30-min infusion of meropenem
Trial: 30326789
Drug: Caffeine (∼3 mg/kg)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (∼3 mg/kg)
Trial: 31469238
Drug: Tocilizumab at
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab at 8 mg/kg/month
Trial: 31469238
Drug: Etanercept at
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept at 50 mg/week
Trial: 29072043
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with Mollii® (transcutaneous electrical stimulation)
Trial: 29072043
Drug: Non-active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-active treatment (placebo)
Trial: 11336156
Drug: Omeprazole treatment
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole treatment
Trial: 11376649
Drug: Loperamide and
RxNorm normalized name: Loperamide and simeticone only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide and Acetaminophen
Trial: 24588066
Drug: Adjunctive emotion
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive emotion regulation group therapy (ERGT)
Trial: 19756419
Drug: Continuous 24-h
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous 24-h infusion of 100 mg/kg per day ceftazidime
Trial: 15063387
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg lycopene/day (Group B)
Trial: 1536016
Drug: 0.5 ml
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml (2.0 mg) of chymopapain and 2.0 ml (8.0 mg) of chymopapain
Trial: 12701008
Drug: Endoscopic epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endoscopic epinephrine injection therapy for gastric body Dieulafoy lesions
Trial: 1863900
Drug: Long-term immunotherapy
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term immunotherapy (more than 2 years)
Trial: 1863900
Drug: Short-term immunotherapy
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term immunotherapy (less than 1 year)
Trial: 1863900
Drug: Immunotherapy (general)
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (general)
Trial: 16732060
Drug: Intracoronary radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary radiation therapy (ICRT) with 14 Gy
Trial: 1752115
Drug: Epoetin beta
RxNorm normalized name: Epoetin beta
DrugBank: Epoetin beta (DB19434)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Epoetin beta (subcutaneous)
Trial: 19501900
Drug: Active control
RxNorm normalized name: Accu-Chek Active Control Solution
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active control (combination of metformin and sulfonylurea, n=2227)
Trial: 31771921
Drug: Higher protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher protein diet (1.2 g protein/kg BW)
Trial: 26864371
Drug: Concord grape
RxNorm normalized name: Concord Grape
DrugBank: Concord grape (DB10875)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concord grape juice (CGJ) - 12 ounces (355 mL) daily for 12 weeks
Trial: 11231941
Drug: Naproxen, 500
RxNorm normalized name: Naproxen, 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen, 500 mg twice daily for 5 days
Trial: 1734637
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) (10 mg)
Trial: 18394900
Drug: Hybrid therapies
RxNorm normalized name: Amaranthus hybridus pollen
DrugBank: Amaranthus hybridus pollen (DB15503)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid therapies
Trial: 12804345
Drug: Aerobic exercises
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerobic exercises (walking or stationary cycling) or a combination of aerobic plus spinal flexibility exercises for 1 hour 3 days a week for 3 months
Trial: 10678643
Drug: Mefar dosimeter
RxNorm normalized name: sulfacetamide sodium Medicated Liquid Soap [Mexar]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefar dosimeter protocol (PD20 value of <=0.5 mg)
Trial: 11380067
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg dose of metronidazole
Trial: 7767
Drug: Formula 4
RxNorm normalized name: Formula 405 Soap
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula 4 (3.0 gm of protein per 100 ml, 18:82)
Trial: 29471855
Drug: 16 sessions
RxNorm normalized name: Alpinia Sessilis Root
DrugBank: Kaempferia galanga root (DB14288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 sessions of eye movement desensitization and reprocessing (EMDR) therapy preceded by a stabilization phase (8 sessions of Skills Training in Affect and Interpersonal Regulation (STAIR))
Trial: 23731911
Drug: Off therapy
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Off therapy
Trial: 2651248
Drug: Dosulepin (Idom)
RxNorm normalized name: dosulepin
DrugBank: Dosulepin (DB09167)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dosulepin (Idom) 75 mg daily in the evening
Trial: 19146991
Drug: Concurrent marginal
RxNorm normalized name: Culex marginalis
DrugBank: Culex pipiens (DB14165)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent marginal maximum likelihood (MML)
Trial: 16710252
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of perindopril (2 mg) and indapamide (0.625 mg)
Trial: 16441782
Drug: Subgingival plaque
RxNorm normalized name: Plaquenil
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subgingival plaque samples from peri-implant pockets
Trial: 29412521
Drug: Endobronchially administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endobronchially administered adipose-derived stem cells (ADSCs)
Trial: 24803644
Drug: VR group
RxNorm normalized name: Prostin VR
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VR group (n=11) received nine 30 minutes upper extremity VR therapy in standing plus conventional therapy
Trial: 26868210
Drug: Bronchodilator use
RxNorm normalized name: Bronchodil
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilator use
Trial: 20968113
Drug: High polyphenol
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High polyphenol chocolate (45 g daily for 8 weeks)
Trial: 20968113
Drug: Low polyphenol
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low polyphenol chocolate (45 g daily for 8 weeks)
Trial: 18552464
Drug: Interferon-beta therapy
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-beta therapy (6 MU daily for 6 or 8 weeks)
Trial: 7094972
Drug: Neomycin sulphate
RxNorm normalized name: Neomycin sulphate
DrugBank: Neomycin (DB00994)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neomycin sulphate 1.5 g/d and d‐thyroxine 6 mg/d for 8 weeks
Trial: 23799935
Drug: Omalizumab +
RxNorm normalized name: Omalizumab
DrugBank: Omalizumab (DB00043)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Omalizumab + Specific Immunotherapy (SIT)
Trial: 23799935
Drug: Specific Immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific Immunotherapy (SIT) + Placebo
Trial: 31256014
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (10 sessions, two times per week)
Trial: 31303281
Drug: Lusutrombopag (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lusutrombopag (0.75 mg) in fed state
Trial: 28355708
Drug: Intravenous injection
RxNorm normalized name: Meta Trace FDG, intravenous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous injection of Ginkgo biloba (Ginaton) 70 mg once a day for 2 weeks
Trial: 10965516
Drug: Yogurt treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yogurt treatment (2 cups, 454 g/day) for three months
Trial: 31536806
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (CEE 0.625 mg/day) plus medroxyprogesterone acetate (MPA 2.5 mg/day)
Trial: 19317814
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg of Ca(2+) orally, daily for 8 weeks
Trial: 10831926
Drug: Graded hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded hormone replacement therapy (HRT) doses
Trial: 24178236
Drug: Mirabegron OCAS
RxNorm normalized name: Mirabegron
DrugBank: Mirabegron (DB08893)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mirabegron OCAS 100-200 mg once daily for 7 days
Trial: 19209184
Drug: Hydroxypropylmethylcellulose (HPMC)
DrugBank: Hypromellose (DB11075)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxypropylmethylcellulose (HPMC) 2.5 g twice daily for 4 weeks
Trial: 31112652
Drug: Phonomotor treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phonomotor treatment
Trial: 19458163
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of methotrexate (MTX) and sulfasalazine (SSZ) in patients who previously failed SSZ
Trial: 18086463
Drug: Open-label PUFA
RxNorm normalized name: strontium chloride, 89Sr-labeled
DrugBank: Strontium chloride Sr-89 (DB09498)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label PUFA administration
Trial: 20967993
Drug: solifenacin (vesikar)
DrugBank: Solifenacin (DB01591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: solifenacin (vesikar) 5 mg/day
Trial: 12821733
Drug: Matching IV
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matching IV and oral placebos
Trial: 23015750
Drug: Group Cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Cognitive Behaviour Therapy (CBT) - 6 sessions
Trial: 20414695
Drug: Hot-pack +
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hot-pack + laser therapy (acute LDH, n = 20)
Trial: 20414695
Drug: Hot-pack +
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hot-pack + laser therapy (chronic LDH, n = 20)
Trial: 29635419
Drug: BCG vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccine in other children (not born by cesarean section)
Trial: 29635419
Drug: BCG vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccine in premature children
Trial: 29635419
Drug: BCG vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccine in children born at term
Trial: 17587516
Drug: tibolone 2.5
RxNorm normalized name: tibolone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tibolone 2.5 mg/day
Trial: 25049330
Drug: Sequential everolimus
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sequential everolimus then sunitinib
Trial: 7590572
Drug: Granular formulation
RxNorm normalized name: Saxifraga granulata whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granular formulation of sucralfate (2.0 g twice daily)
Trial: 30643079
Drug: Dabigatran 110
RxNorm normalized name: dabigatran 110 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 110 mg dual therapy
Trial: 23224788
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg aprepitant
Trial: 21109344
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg
Trial: 29667763
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg
Trial: 8633187
Drug: felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: felodipine 5 mg
Trial: 17264338
Drug: Intravenous fluorouracil
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fluorouracil (FU) plus leucovorin (LV)
Trial: 7995059
Drug: Single pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single pulse therapy (500 mg of methylprednisolone)
Trial: 7995059
Drug: Second pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second pulse therapy at 24 hours (500 mg of methylprednisolone)
Trial: 7995059
Drug: Second pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second pulse therapy at 48 hours (500 mg of methylprednisolone)
Trial: 17229251
Drug: Volunteer-mediated intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Volunteer-mediated intervention (daily orientation, therapeutic activities, feeding and hydration assistance, vision and hearing protocols)
Trial: 12799847
Drug: Tramadol 50
RxNorm normalized name: traMADol 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 50 mg
Trial: 31974099
Drug: Rapid insulin-alone
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rapid insulin-alone artificial pancreas
Trial: 21385145
Drug: Rivaroxaban 10
RxNorm normalized name: rivaroxaban 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 10 mg once daily after THR
Trial: 17446716
Drug: Topical administration
RxNorm normalized name: Octocaine 5 % Ointment for Oral and Topical Administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical administration of lutein and zeaxanthin
Trial: 8299431
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (d‐alpha‐tocopherol; 900 mg/day)
Trial: 16163899
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg Ticlid tablets (reference formulation)
Trial: 14585916
Drug: COX-2-specific inhibitors
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: COX-2-specific inhibitors (celecoxib or valdecoxib)
Trial: 1763292
Drug: Prednisolone 25
RxNorm normalized name: prednisolone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 25 mg/100 ml
Trial: 29264713
Drug: Liraglutide 0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide 0.9 mg
Trial: 21980798
Drug: Specific sublingual
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific sublingual immunotherapy (SLITOne, ALK) for two consecutive pollen seasons
Trial: 28459989
Drug: Experimental intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Experimental intervention (EX): Usual care (nutrition and PA education materials) plus 2‐month supervised weekly physical activity and behaviour change sessions.
Trial: 7639342
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg d-alpha-tocopherol per day for 3 weeks
Trial: 7639342
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg d-alpha-tocopherol per day for 3 weeks
Trial: 14587651
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR (20 mg/day)
Trial: 6761928
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 2 mg pessaries administered four hourly
Trial: 25085073
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus GG (L.GG)
Trial: 19287552
Drug: Adjunctive aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adjunctive aripiprazole (2-20 mg/day)
Trial: 12725663
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen (50 microg estradiol patch weekly)
Trial: 17664149
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1 g intravenous infusion)
Trial: 16225161
Drug: MR carbonyl
RxNorm normalized name: Iron, Carbonyl
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MR carbonyl iron (45 mg)
Trial: 26781763
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (1000 IU) and Evening Primrose Oil (1000 mg)
Trial: 18616780
Drug: Triple combination
RxNorm normalized name: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%)
Trial: 9829447
Drug: Hydroquinone 4%
RxNorm normalized name: HYDROQUINONE 4% CREAM
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroquinone 4% cream
Trial: 6382936
Drug: meglumine iothalamate
RxNorm normalized name: meglumine ioxithalamate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meglumine iothalamate 280 mg I/ml
Trial: 6377118
Drug: iohexol 300
RxNorm normalized name: IOHEXOL 300MG/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iohexol 300 mg I/ml
Trial: 22550196
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil capsules (four 1-g capsules/d)
Trial: 18958837
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy in critically ill non-ACS patients
Trial: 20819892
Drug: MF59-adjuvanted H5N1
RxNorm normalized name: Influenza A monovalent (H5N1), ADJUVANTED-2013
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted H5N1 vaccine (7.5 μg/dose)
Trial: 10050562
Drug: Glucosamine HCl
RxNorm normalized name: glucosamine HCl
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine HCl (1,500 mg/day), chondroitin sulfate (1,200 mg/day), and manganese ascorbate (228 mg/day)
Trial: 19349517
Drug: Nikkomycin Z
RxNorm normalized name: Nikkomycin Z
DrugBank: Nikkomycin Z (DB12939)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nikkomycin Z 1,000 mg
Trial: 19349517
Drug: Nikkomycin Z
RxNorm normalized name: Nikkomycin Z
DrugBank: Nikkomycin Z (DB12939)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nikkomycin Z 1,500 mg to 2,000 mg
Trial: 8692147
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (10 mg) given via portal system for intestinal type
Trial: 8692147
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (10 mg) given in peritoneal cavity for diffuse type
Trial: 8203796
Drug: Flunisolide nasal
RxNorm normalized name: flunisolide nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunisolide nasal spray
Trial: 9328492
Drug: Intensive psychosocial
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive psychosocial treatment
Trial: 8146409
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg salbutamol CR twice daily
Trial: 7020820
Drug: all 3
RxNorm normalized name: Small 33G Lancet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: all 3 antibiotics
Trial: 1300782
Drug: Adjuvant hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjuvant hormone therapy in ER+PR+ tumor patients